Lumanity

Name

Lumanity

Legal name

Lumanity Inc

Website

https://lumanity.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Lumanity is a privately held life sciences commercialization partner serving more than 80% of top pharmaceutical companies and hundreds of biotechs with consulting, HEOR, real-world evidence, market access, and an integrated AI-enabled technology platform across North America and Europe.

Ownership category

akta.pro rank

Product category

Life Sciences Commercialization Consulting

NAICS

Management Consulting Services (54161), Marketing Consulting Services (541613)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industry

Medical Information Services (MI Contact Centers) (HLAGALAE)

Keywords

• Life sciences consulting
• Pharmaceutical commercialization
• Medical affairs services
• Biotech evidence generation
• Healthcare market access

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Consulting Services: Lumanity provides consulting services across commercialization strategy, health economics and outcomes research, clinical and regulatory affairs, medical affairs, and patient engagement. Services are delivered by teams of experts including consultants, former industry leaders, scientists, and therapeutic area specialists.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Core offering

Lumanity is a life sciences commercialization partner that combines consulting services with proprietary technology platforms to help pharmaceutical, biotech, and medical device companies accelerate the development and launch of therapies. The company delivers strategy, evidence, and engagement services, alongside AI-enabled platforms such as Ignite, EMULaiTOR, Expert Navigator, Pathway, ONEE, WeConvEEn, Engage, and Sonar. It serves more than 80% of top global pharmaceutical companies across North America (Morristown, NJ) and Europe (London).

Product overview

Lumanity offers an integrated suite of technology products for life sciences commercialization, combining AI-powered solutions with strategic platforms. The portfolio includes EMULaiTOR (AI-powered synthetic persona platform), Ignite (cloud-based launch excellence software), Expert Navigator (KOL mapping and engagement solution), Pathway (patient journey mapping tool), ONEE (omnichannel engagement platform), WeConvEEn (engagement coordination), Engage (HCP insight reporting), and Sonar (social media patient tracking). These products are interconnected through Lumanity's Expert-Directed Applied Intelligence (EDAI) ecosystem and GAIL generative AI platform, enabling end-to-end support from launch planning through patient engagement and real-world evidence generation.

Differentiator

Problem solved

Functional benefit

Brands

• Ignite: Comprehensive cloud-based launch excellence software platform for pharma launch planning, providing real-time master plans, collaboration tools, and detailed action planning
• EMULaiTOR
• Expert Navigator
• Pathway
• ONEE (Omnichannel Network Engagement Experience)
• PHARMO Institute

Products and services

• Ignite Proprietary AI-enabled platform supporting life sciences commercialization and launch readiness activities.
• EMULaiTOR Proprietary technology platform for evidence generation and simulation supporting pharma and biotech clients.
• Expert Navigator Proprietary platform enabling identification and engagement of clinical and scientific experts in life sciences.
• Pathway Proprietary technology platform for commercial pathway planning and execution in life sciences.
• ONEE Proprietary platform supporting stakeholder engagement and outreach within life sciences commercialization.
• WeConvEEn Proprietary platform facilitating convening and engagement of healthcare stakeholders for life sciences clients.
• Engage Proprietary engagement platform used to connect life sciences organizations with healthcare professionals and stakeholders.
• Sonar Proprietary insights platform supporting market intelligence and stakeholder mapping for life sciences commercialization.
• Commercialization Strategy Consulting Advisory services helping pharmaceutical, biotech, and medical device clients plan and execute therapy commercialization.
• Evidence Generation Services Consulting services supporting real-world evidence, clinical, and health economics evidence generation for life sciences clients.
• Engagement Services Services enabling stakeholder engagement, medical communications, and expert interaction for pharmaceutical and biotech clients.

Quantifiable outcome

• Secured higher Maximum Fair Price than competition for leading pharmaceutical manufacturer under IRA
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature10 records

Partnerships

Four partnerships are on record, tiered core and minor.

• The PHARMO InstitutecoreStrategic or Co-development PartnerPHARMO Institute is an organization dedicated to developing cutting-edge solutions for enhanced RWE analytics, focusing on pharmacoepidemiology, drug utilization, drug safety, and health outcomes. Part of Lumanity, it provides direct access to longitudinal anonymized patient-level data from the Netherlands and is a top 10 trusted source by the EMA.
• SIGMA ConsortiumcoreStrategic or Co-development PartnerCo-founded by PHARMO, provides global reach and integrated expertise from leading EU research centers for real-world evidence generation.
• VAC4EU (Vaccine Collaboration)minorStrategic or Co-development PartnerEuropean collaboration for harmonizing case validation for vaccine safety in real-world data.
• AVEO OncologyminorStrategic or Co-development PartnerAVEO Oncology partnered with Lumanity to leverage PulsePoint's NPI-Level Insights and Media Capabilities for oncology marketing campaigns.

Scale indicators15 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• McKinsey & Company (Pharma Practice): McKinsey's pharma and medical products practice covers commercialization strategy, corporate development, and operating model design for top pharmaceutical companies. Competes with Lumanity for high-end strategic consulting mandates at the same Fortune 100 pharma clients.
• IQVIA: IQVIA is the largest life sciences services firm, combining CRO functions with commercialization, HEOR, RWE, and technology offerings. Directly overlaps Lumanity across HEOR, real-world evidence, and commercial strategy, but operates at vastly greater scale with a broader portfolio that includes clinical trial execution and primary data assets.
• ICON plc: ICON is a major global CRO with growing commercialization, HEOR, and real-world evidence capabilities following its PRA Health Sciences and other acquisitions. Competes with Lumanity in commercial strategy, RWE, and patient-centered outcomes engagements for pharma and biotech sponsors.

Direct peers

• Trinity Life Sciences: Trinity Life Sciences is a life sciences strategy and insights firm spanning commercial strategy, market access, real-world evidence, and patient-centric research. Directly comparable to Lumanity across strategy, HEOR, market insights, and AI-enabled platforms for pharma commercialization.
• ZS Associates: ZS Associates is a global management consulting firm with a large life sciences practice covering commercial strategy, sales, marketing, and analytics, including KOL and patient engagement platforms. Directly comparable to Lumanity on pharma commercialization consulting and thought-leadership mapping technology.
• CBPartners: CBPartners is a specialized life sciences consulting firm focused on pricing, market access, and value demonstration for pharma and biotech. Closely comparable to Lumanity's value, access and HEOR practice in serving top-pharma and emerging biotech with payer evidence work.
• Putnam Associates: Putnam Associates is a focused biopharmaceutical strategy consulting firm specializing in commercialization, market access, and pricing strategy for pharma and biotech. Directly comparable to Lumanity's strategy consulting and BioConsulting practice, serving similar clients at similar engagement size.
• Syneos Health: Syneos Health (now privately held post-take-private) provides contract clinical research plus commercialization services to pharma, including medical affairs, market access, and patient engagement. Highly comparable to Lumanity as a similar full-stack life sciences commercialization partner serving the same top-pharma customer base.
• Clarivate: Clarivate (including the former Decision Resources Group) provides data, analytics, and consulting for life sciences commercialization, including market access and HEOR. Comparable to Lumanity in life sciences evidence generation and commercialization insights, with stronger data-product business.
• Avalere Health: Avalere Health is a specialized life sciences consulting firm focused on market access, HEOR, policy, and commercialization strategy for biopharma. Closest peer to Lumanity's HEOR, payer, and policy practice, serving overlapping top-pharma clients with comparable advisory and evidence-generation offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/lumanity
• LinkedInlinkedin.com/company/lumanity

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lumanity